Business Segments |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jul. 04, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Segments | 13. Business Segments The Company operates in one segment: ophthalmology. The Company develops, manufactures and markets medical devices. The Company’s revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities. Revenue information shown by product group is as follows (in thousands):
(1) Includes service contract revenues of $305 thousand and $277 thousand and $654 thousand and $611 thousand recognized during the three and six months ended July 4, 2026 and June 28, 2025, respectively. Includes $0.3 million and $0.7 million recognized revenue related to the exclusive distribution rights during both of the three and six months ended July 4, 2026 and June 28, 2025, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.
Revenue information shown by geographic region, based on the sales destination, is as follows (in thousands):
Revenues are attributed to countries based on the location of end customers. The United States accounted for 40.8% and 42.4% of revenues for the three months ended July 4, 2026 and June 28, 2025, respectively, and 45.1% and 43.4% for the six months ended July 4, 2026 and June 28, 2025, respectively. Other than the United States, China, Japan, and the Netherlands accounted for at least 10% of the Company’s revenues during the three months ended July 4, 2026 and June 28, 2025, representing less than 10%, 14%, 15%, and 15%, representing less than 10%, 12%, respectively. Other than the United States, China and the Netherlands accounted for at least 10% of the Company’s revenues during the six months ended July 4, 2026 and June 28, 2025, representing less than 10% and 15%, and 12% and 12%, respectively. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||